Posts

Key TakeawaysA new test can measure the amount of COVID-19 antibodies someone has in a small sample of blood. The method uses an enzyme called luciferase, which is the same enzyme that makes fireflies glow.Not only does it reveal if antibodies are present, but it can measure how much of an antibody response someone currently has. That information could help experts understand how well vaccines are working and how much protection someone has after a natural infection....

Key TakeawaysUpdated versions of COVID vaccines from Pfizer and Moderna earnedFDA approvalon Monday.While initially designed to target June’s dominant variant of XBB.1.5, research shows these vaccines should protect against newer variants, like BA.2.86, as well.The FDA has not yet greenlit an updated version of Novavax’s COVID vaccine. Key Takeaways Updated versions of COVID vaccines from Pfizer and Moderna earnedFDA approvalon Monday.While initially designed to target June’s dominant variant of XBB.1.5, research shows these vaccines should protect against newer variants, like BA....

Key TakeawaysIndividuals who survive cardiac arrest and their caregivers need continued support during and after their recovery.The American Heart Association recommends adding a new link to the CPR “Chain of Survival” that addresses cardiac arrest survivors’ ongoing needs.Spreading awareness of the new guidelines among healthcare providers and the public is key to implementing change. Key Takeaways Individuals who survive cardiac arrest and their caregivers need continued support during and after their recovery....

Key TakeawaysResearchers identified criteria for people who are more likely to experience a cytokine storm.This dangerous complication of COVID-19 and other infections can turn deadly.The criteria are preliminary at this point, and can hopefully lead to improved treatment. Key Takeaways Researchers identified criteria for people who are more likely to experience a cytokine storm.This dangerous complication of COVID-19 and other infections can turn deadly.The criteria are preliminary at this point, and can hopefully lead to improved treatment....

Key TakeawaysA new device that was designed to help people lose weight is facing backlash, as experts say that it is medically unsound and harmful.The DentalSlim Diet Control device uses magnets on the wearer’s back teeth to restrict the mouth’s ability to fully open. With limited jaw mobility, people wearing the device must adhere to a liquid diet.Experts say that the device is dangerous and puts people at risk of developing disordered eating....

Key TakeawaysA new study shows that 86% of compliant study participants found tinnitus relief using a process called bimodal neuromodulation.Of the participants who found relief, 66% continued to experience lasting improvement for a year.The device, Lenire, is not yet approved for use in the United States. Key Takeaways A new study shows that 86% of compliant study participants found tinnitus relief using a process called bimodal neuromodulation.Of the participants who found relief, 66% continued to experience lasting improvement for a year....

Key TakeawaysScientists found a way to objectively measure tinnitus, also known as a persistent ringing in the ears, for the first time.The technology measures brain activity and can determine how severe a person’s case of tinnitus is.Researchers are hopeful this tool will improve diagnosis and treatment options for the condition, which is linked to sleep disturbances, anxiety, and depression. Key Takeaways Scientists found a way to objectively measure tinnitus, also known as a persistent ringing in the ears, for the first time....

Key TakeawaysA small clinical study showed that a new RNA-targeted medication lowered blood pressure for up to six months.Zilebesiran is injected straight into the liver, targeting its effects there.Current hypertension medications focus on hormones that cause high blood pressure; this one targets the RNA that creates the hormones.The drug is years from market, but research is ongoing. Key Takeaways A small clinical study showed that a new RNA-targeted medication lowered blood pressure for up to six months....

Key Takeaways Rheumatoid arthritis(RA) is a painful autoimmune disease of the joints that causes pain and loss of function. A clinical trial of a new drug called olokizumab showed it was at least as effective as the currently available standard treatments for RA. Mild RA can be treated withnonsteroidal anti-inflammatory drugs(NSAIDs) like ibuprofen or naproxen orcorticosteroids. The current standard of care for moderate-to-severe RA is using one or moredisease-modifying antirheumatic drugs(DMARDs), such as methotrexate, adalimumab, or tofacitinib....

Key TakeawaysThe FDA approved pralsetinib (Gavreto), a selective RET-inhibitor drug, for RET fusion-positive non-small cell lung cancers (NSCLC) on September 4, 2020, and RET-altered thyroid cancers on December 1, 2020.This medication, and others like it, provide a more targeted treatment option for patients with these diagnoses.Willing clinical trial participants can shape the future of cancer care for others. Key Takeaways The FDA approved pralsetinib (Gavreto), a selective RET-inhibitor drug, for RET fusion-positive non-small cell lung cancers (NSCLC) on September 4, 2020, and RET-altered thyroid cancers on December 1, 2020....

Key TakeawaysPulmonary arterial hypertension is a rare, incurable, progressive condition that causes fatigue and difficulty breathing. It’s a type of high blood pressure in the lungs.A recent clinical study showed that a new drug, sotatercept, can improve the quality of life for individuals with pulmonary arterial hypertension. The drug recently received FDA approval.Patients living with pulmonary arterial hypertension have treatment options, and they can find the support and resources needed to manage their condition....

Key TakeawaysA new drug boosts growth in children with achondroplasia, a common form of dwarfism.In a clinical trial, children who took the drug grew an average of 1.5 centimeters more than those who did not take the drug.Researchers say it shows promise for the treatment of achondroplasia. Key Takeaways A new drug boosts growth in children with achondroplasia, a common form of dwarfism.In a clinical trial, children who took the drug grew an average of 1....

Key TakeawaysOlder adults with acute myeloid leukemia have a high incidence of relapse and low survival rates.A new medication provides an option for some patients who are not candidates for more aggressive measures during the maintenance phase of treatment. Key Takeaways Older adults with acute myeloid leukemia have a high incidence of relapse and low survival rates.A new medication provides an option for some patients who are not candidates for more aggressive measures during the maintenance phase of treatment....